Dependent variables | Serum 25 (OH)D statusa | Regression model 1b | Regression model 2c | ||||
---|---|---|---|---|---|---|---|
Deficiency (<20 ng/ml) | Insufficiency (20-29 ng/ml) | Sufficiency (>30 ng/ml) | β | P | β | P | |
Subjects (n) | 422 | 1602 | 684 | ||||
FG, mmol/L | 5.3 (3.6-11.5)* | 5.0 (3.1-9.3) | 4.9 (2.7-8.8) | −0.086 | 0.011 | −0.055 | 0.034 |
PG, mmol/L | 8.5 (3.7-13.9)* | 7.8 (3.5-12.4) | 7.7 (3.2-12.1) | −0.091 | 0.002 | −0.058 | 0.027 |
HbAlc, % | 4.4 (3.3-11.5)** | 4.2 (3.2-11.8)** | 4.0 (3.3-11.6) | −0.120 | <0.001 | −0.082 | 0.012 |
Insulin, mU/L | 5.9 (1.5-16.9) | 6.1 (1.4-17.8) | 6.0 (1.6-18.1) | −0.045 | 0.051 | −0.042 | 0.058 |
HOMA-IR | 1.5 (0.3-6.5)** | 1.4 (0.3-6.1)* | 1.3 (0.3-5.8) | −0.127 | <0.001 | −0.048 | 0.047 |
TC, mmol/L | 5.0 ± 1.2 | 4.8 ± 1.3 | 4.8 ± 1.2 | −0.014 | 0.532 | −0.015 | 0.525 |
TG, mmol/L | 1.8 (0.8-6.3)* | 1.6 (0.5-6.1) | 1.5 (0.6-5.8) | −0.093 | 0.001 | −0.043 | 0.056 |
HDL-C, mmol/L | 1.4 (0.7-2.2)* | 1.5 (0.8-2.4) | 1.5 (0.8-2.3) | 0.117 | <0.001 | 0.084 | 0.011 |
LDL-C, mmol/L | 3.0 (0.8-5.3) | 2.9 (0.7-5.2) | 2.9 (0.5-5.5) | −0.021 | 0.431 | −0.018 | 0.513 |
apoA, mmol/L | 1.9 ± 0.4* | 2.0 ± 0.4 | 2.0 ± 0.3 | 0.089 | 0.005 | 0.052 | 0.028 |
apoB, mmol/L | 0.8 ± 0.2 | 0.8 ± 0.3 | 0.8 ± 0.2 | 0.024 | 0.353 | 0.022 | 0.358 |
FFAs, μmol/L | 778.6 ± 284.8** | 734.5 ± 306.4* | 672.8 ± 297.5 | −0.145 | <0.001 | −0.077 | 0.021 |
LPL, U/L | 615.3 ± 192.4** | 658.8 ± 196.6* | 691.2 ± 194.1 | 0.168 | <0.001 | NA | NA |